M
Michael J. Mack
Researcher at Scott & White Hospital
Publications - 634
Citations - 36680
Michael J. Mack is an academic researcher from Scott & White Hospital. The author has contributed to research in topics: Valve replacement & Medicine. The author has an hindex of 89, co-authored 519 publications receiving 28877 citations. Previous affiliations of Michael J. Mack include Baylor University Medical Center & Medical City Dallas Hospital.
Papers
More filters
Journal ArticleDOI
The train has left: Can surgeons still get a ticket to treat structural heart disease?
Tom C. Nguyen,Gilbert H.L. Tang,Stephanie Nguyen,Jessica Forcillo,Isaac George,Tsuyoshi Kaneko,Vinod H. Thourani,Joseph E. Bavaria,Anson Cheung,Michael J. Reardon,Michael J. Mack +10 more
TL;DR: Given the variability in structural heart training, it is urgently recommended the establishment of a standardized curriculum and pathways for surgical trainees to gain proficiency in transcatheter technologies.
Journal ArticleDOI
Sex Differences in All-Cause Mortality in the Decade Following Complex Coronary Revascularization.
Hironori Hara,Kuniaki Takahashi,David van Klaveren,Rutao Wang,Scot Garg,Masafumi Ono,Hideyuki Kawashima,Chao Gao,Michael J. Mack,David R. Holmes,Marie-Claude Morice,Stuart J. Head,Arie Pieter Kappetein,Daniel J F M Thuijs,Yoshinobu Onuma,Thilo Noack,Friedrich W. Mohr,Piroze M. Davierwala,Patrick W. Serruys,Patrick W. Serruys,Syntax Extended Survival Investigators +20 more
TL;DR: Female sex was not an independent predictor of mortality at 10 years in patients with complex coronary artery disease in the SYNTAXES study, suggesting that optimal revascularization beyond 5 years according to sex has not been evaluated.
Journal ArticleDOI
Variation in post-TAVR antiplatelet therapy utilization and associated outcomes: Insights from the STS/ACC TVT Registry
Matthew W. Sherwood,Sreekanth Vemulapalli,Harrison Jk,David Dai,Amit N. Vora,Michael J. Mack,David R. Holmes,John S. Rumsfeld,David Cohen,Vinod H. Thourani,Ajay J. Kirtane,Eric D. Peterson +11 more
TL;DR: Patients discharged with DAPT had a similar adjusted risk of mortality, stroke, and MI compared to antiplatelet monotherapy, although risk for bleeding was significantly higher and practice patterns varied significantly among hospitals.
Journal ArticleDOI
Validation of the SYNTAX Revascularization Index to Quantify Reasonable Level of Incomplete Revascularization After Percutaneous Coronary Intervention
Philippe Généreux,Philippe Généreux,Carlos M. Campos,Carlos M. Campos,Vasim Farooq,Christos V. Bourantas,Friedrich W. Mohr,Antonio Colombo,Marie Angèle Morel,Ted Feldman,David R. Holmes,Michael J. Mack,Marie Claude Morice,A. Pieter Kappetein,Tullio Palmerini,Gregg W. Stone,Patrick W. Serruys,Patrick W. Serruys +17 more
TL;DR: The SRI is a useful tool in assessing the degree of revascularization after PCI, with SRI ≥70% representing a "reasonable" goal for patients with complex coronary artery disease.
Journal ArticleDOI
The ABLATE Trial: Safety and Efficacy of Cox Maze-IV Using a Bipolar Radiofrequency Ablation System
Jonathan M. Philpott,Christian W. Zemlin,James L. Cox,MacK Stirling,Michael J. Mack,Robert L. Hooker,Allen Morris,David Heimansohn,James Longoria,Divyakant B. Gandhi,Patrick M. McCarthy +10 more
TL;DR: The CMP-IV using the AtriCure Synergy system was safe and effective for cardiac surgical patients who had persistent and longstanding persistent AF.